The introduction of serology testing would also require the reinforcement of the national health system infrastructure and capacity for optimal test performance and guarantee supply. Attention needs to be paid to ensure the use of high-quality serology assays considering both the analytical (i.e., high-level specificity and sensitivity) and clinical characteristics of patients. Finally, governments should clearly communicate and engage with different stakeholders to raise awareness and ensure access to testing opportunities (see Fig. 2).